China Universal Asset Management Co., Ltd. Iveric Bio, Inc. Transaction History

China Universal Asset Management Co., Ltd.

$893 Million
Q3 2024

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 May 21, 2024	SELL	$26.24 - $39.63 $997 - $1,505	-38 Reduced 2.06%	1,805 $71,000
Q2 2023 Jul 27, 2023	SELL	$26.24 - $39.63 $997 - $1,505	-38 Reduced 2.06%	1,805 $71,000
Q1 2023 May 21, 2024	BUY	$18.67 - $24.56 $11,500 - $15,128	616 Added 50.2%	1,843 $44,000
Q1 2023 Apr 27, 2023	BUY	$18.67 - $24.56 $11,500 - $15,128	616 Added 50.2%	1,843 $45,000
Q4 2022 May 21, 2024	BUY	$17.24 - $23.95 $21,153 - $29,386	1,227 New	1,227 $26,000
Q4 2022 Jan 31, 2023	BUY	$17.24 - $23.95 $2,086 - $2,897	121 Added 10.94%	1,227 $26,000
Q3 2022 Oct 21, 2022	BUY	$9.4 - $18.59 $10,396 - $20,560	1,106 New	1,106 $20,000

Others Institutions Holding ISEE

# of Institutions

Shares Held

250K

Call Options Held

40K

Put Options Held

View Full List

About IVERIC bio, Inc.

Ticker ISEE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,078,000
Description
IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...

More about ISEE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of China Universal Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on China Universal Asset Management Co., Ltd. with notifications on news.

Account